QUINCE THERAPEUTICS, INC.

Transcripts Quince Therapeutics, Inc.

Equities

QNCX

US22053A1079

Delayed Nasdaq Other stock markets 03:49:34 2024-05-30 pm EDT			5-day change	1st Jan Change
0.8314 ^USD	-3.33%		-2.33%	-19.08%

May. 13	Quince Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 01	Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Quince Therapeutics, Inc. - Special Call	Mar. 26
Transcript : Quince Therapeutics, Inc. - Shareholder/Analyst Call	23-05-24
Transcript : Cortexyme, Inc. - Special Call	21-10-26
Transcript : Cortexyme, Inc. Presents at H.C. Wainwright 23rd Annual Global Investment Conference, Sep-13-2021 07:00 AM	21-09-13
Transcript : Cortexyme, Inc. - Special Call	21-07-30
Transcript : Cortexyme, Inc. - Special Call	21-07-23
Transcript : Cortexyme, Inc. Presents at The JMP Securities Life Sciences Conference, Jun-16-2021 03:00 PM	21-06-16
Transcript : Cortexyme, Inc. Presents at Jefferies 2021 Virtual Healthcare Conference, Jun-02-2021 02:00 PM	21-06-02
Transcript : Cortexyme, Inc. Presents at Stifel's 3rd Annual CNS Day, Apr-01-2021 10:00 AM	21-04-01
Transcript : Cortexyme, Inc. Presents at Oppenheimer 31st Annual Healthcare Conference, Mar-16-2021 02:30 PM	21-03-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer